Organization | Yunnan Provincial Hospital of Infectious Diseases

Yunnan Provincial Hospital of Infectious Diseases Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2011

NCT01318096

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Alternative names

Yunnan Provincial Hospital of Infectious Diseases/Yunnan AIDS Care Center | Yunnan Provincial Infectious Disease Hospital

Active Ingredients

Drugs in Other Trials (6)

efavirenz (sustiva) (1 trial)

lamivudine (epivir) (1 trial)

raltegravir (isentress) (1 trial)

rifabutin (mycobutin) (1 trial)

rifampin (1 trial)

tenofovir (viread) (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 2
# of Trial APIs: 6